Medicis Pharmaceutical Corp. (MRX) Reports In-Line Q2 EPS of 64c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $71.38 -1.03%
Financial Fact:
Interest and investment income: -950K
Today's EPS Names:
VIVE, ENSV, MDLM, More
Financial Fact:
Interest and investment income: -950K
Today's EPS Names:
VIVE, ENSV, MDLM, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q2 EPS of $0.64, in-line with the analyst estimate of $0.64. Revenue for the quarter came in at $190.8 million versus the consensus estimate of $188.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
- Best Buy (BBY) Tops Q2 EPS by 12c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
